IRCCS Humanitas Research Hospital
Rozzano, MI, 20089, Italy
NCT Number: NCT06615583
The goal of this pilot clinical trial is provide preminary evidence of the effectiveness of the C-REX device, developed by CarpoNovum AB, in preventing anastomotic leak and improving anastomosis healing after sigmoid or high rectal resection in patients with colon neoplasia. The primary aim of the study is to evaluate the rate of anastomotic leak in patients receiving the study device within 90 days from the surgical procedure.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Rozzano, MI, 20089, Italy
Despite technological advancements, the rate of anastomotic leak after left colon and high rectal resection remains high, around 20%. The device C-REX, developed by CarpoNovum, may help the anastomosis construction and promote its healing. This may lead to reduced anastomotic leak rate and severity. This study aims to collect preliminary evidence on the effectiveness of C-REX to develop a future larger multicentric trial. This pilot study will collect preliminary data on the rate and severity of 90-day anastomotic leak in patients receiving the C-REX device.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The C-REX device consists of an invasive surgical part, including two anastomotic rings, and surgical instruments for assisting the placement of the anastomotic ring to intestine. The rings are loosen from the inside of the intestinal wall and expelled with faeces per rectum once the anastomosis is healed in approximately ten days.
Time frame: 90 days after surgery
Rate of radiologically confirmed anastomotic leaks and their severity according to the International Study Group of Rectal Cancer (ISGR) grade
Time frame: Intraoperative
Rate of intraoperative anastomotic construction failures, as confirmed by positive air leak test, reverse air leak test, or C-REX integrity pressure test after anastomosis construction
Time frame: Intraoperative
Median time (in minutes) required to construct the anastomosis using the C-REX device
Time frame: Ten days after surgery
Median time required to evacuate the anastomotic ring of the C-REX device, in days
Time frame: 90 days after surgery
Incidence rate of anastomotic stenosis, as confirmed by digital endoscopy
Contact information is provided by the study sponsor or research team.
Annalisa Maroli, Ph.D.
CONTACT
02 8224 7776 ext. 0039
Stefano De Zanet
CONTACT
02 8224 4623 ext. 0039
Istituto Clinico Humanitas
Other
A Novel Adaptive Anastomotic Technique for Left-sided Colonic and Rectal Resection: a Pilot, Single-center, Prospective, Case-series Study
Acronym: NOVA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07450612
Adenoma Colon, Adenoma Colon Polyp
Milan, Lombardy, Italy
View Trial DetailsNCT07427537
Cancer, Lung, Colon Neoplasm
Clermont-Ferrand, France
View Trial DetailsNCT04369053
Adenoma, Colon Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT05551052
Adenoma, Adenomas Colon
Chula Vista, California, United States
View Trial Details